新生血管性年龄相关性黄斑变性缓解期纤维细胞性与纤维血管性表型的解剖与功能改变比较
研究纳入已治疗并处于缓解期(无视网膜下出血、无视网膜内或下积液、至少6个月未治疗)的新生血管性AMD眼,按多色影像上是否存在纤维化分为纤维细胞性组和纤维血管性组,比较解剖改变与黄斑功能。纤维细胞性组视力更差、RPE萎缩比例更高、病灶灌注密度更低。
要点
- 纤维细胞性组最佳矫正视力0.7±0.5 LogMAR,纤维血管性组0.3±0.2 LogMAR(p=0.003)。
- 纤维细胞性组17/19眼、纤维血管性组8/22眼出现RPE萎缩(p=0.001)。
- 病灶内灌注密度纤维细胞性组28.9%±9.9%,纤维血管性组44.2%±5.9%(p<0.0001)。
核心结论
- 缓解期新生血管性AMD伴纤维细胞性瘢痕的眼表现为RPE萎缩和灌注减少,并与更严重的功能损害相关。
- 作者认为,纤维化中血管的成熟可能是新生血管性AMD治疗中更好的靶点,而非消除血管。
研究设计与样本
- 纳入既往治疗过且处于缓解期的新生血管性AMD眼,缓解定义为无视网膜下出血、无视网膜内或下积液、至少6个月未治疗。
- 受试者接受多模态影像评估,并使用微视野计检测黄斑敏感度。
- 按多色影像上是否存在纤维化分为纤维细胞性组和纤维血管性组。
主要发现
- 19眼在多色影像上分类为纤维细胞性,22眼分类为纤维血管性。
- 纤维细胞性组平均年龄73.9±11.0岁,纤维血管性组75.9±7.1岁(p=0.221)。
- 纤维细胞性组最佳矫正视力0.7±0.5 LogMAR,纤维血管性组0.3±0.2 LogMAR(p=0.003)。
- 光学相干断层扫描和眼底自发荧光评估显示,纤维细胞性组17/19眼、纤维血管性组8/22眼存在RPE萎缩(p=0.001)。
- 新生血管病灶内灌注密度纤维细胞性组28.9%±9.9%,纤维血管性组44.2%±5.9%(p<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the anatomical changes and the macular function in neovascular age-related macular degeneration (AMD) eyes, according to the recognition of either fibrocellular or fibrovascular phenotype. METHODS: We enrolled eyes with previously treated neovascular AMD in remission (no subretinal haemorrhage, sign of fluid in or under the retina and no treatment for at least 6 months). Subjects underwent multimodal imaging assessment and were tested for macular sensitivity using microperimetry. The study cohort was divided according to the presence of fibrosis on multicolour (MC) images, yielding two distinct phenotypic subgroups: (1) fibrocellular group and (2) fibrovascular group. RESULTS: Nineteen eyes were classified as fibrocellular on MC images, while 22 eyes as fibrovascular. Mean±SD age was 73.9±11.0 years in the fibrocellular group and 75.9±7.1 years in the fibrovascular group (p=0.221). Best-corrected visual acuity was 0.7±0.5 logarithm of the minimum angle of resolution (LogMAR) in the fibrocellular group and 0.3±0.2 LogMAR in the fibrovascular group (p=0.003). On the optical coherence tomography and fundus autofluorescence evaluation, 17/19 eyes with the fibrocellular phenotype and 8/22 eyes with the fibrovascular phenotype displayed the presence of retinal pigment epithelium (RPE) atrophy (p=0.001). The perfusion density within the neovascular lesion was 28.9%±9.9% in the fibrocellular group and 44.2%±5.9 % in the fibrovascular group (p<0.0001). CONCLUSION: Neovascular AMD eyes in remission and with evidence of fibrocellular scar are characterised by RPE atrophy and reduced perfusion, which are associated with a higher degree of functional impairment. These findings suggest that maturation of vessels in fibrosis might be a better target in neovascular AMD treatments rather than their abolishment.
引用
- Querques L, Parravano M, Borrelli E, et al. Anatomical and functional changes in neovascular AMD in remission: comparison of fibrocellular and fibrovascular phenotypes. Br J Ophthalmol. 2019. PMID: 31000509. doi:10.1136/bjophthalmol-2018-313685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。